Page last updated: 2024-11-07

carbachol and Chediak-Higashi Syndrome

carbachol has been researched along with Chediak-Higashi Syndrome in 2 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Chediak-Higashi Syndrome: A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katz, P1
Roder, JC1
Zaytoun, AM1
Herberman, RB1
Fauci, AS1
Oliver, JM1
Krawiec, JA1
Berlin, RD1

Other Studies

2 other studies available for carbachol and Chediak-Higashi Syndrome

ArticleYear
Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak-Higashi syndrome with inducers of intracellular cyclic GMP.
    Journal of immunology (Baltimore, Md. : 1950), 1982, Volume: 129, Issue:1

    Topics: Adult; Atropine; Bucladesine; Carbachol; Cell Line; Cell Survival; Chediak-Higashi Syndrome; Cyclic

1982
Carbamycholine prevents giant granule-formation in cultured fibroblasts from beige (Chediak-Higashi) mice.
    The Journal of cell biology, 1976, Volume: 69, Issue:1

    Topics: Atropine; Carbachol; Cells, Cultured; Chediak-Higashi Syndrome; Dose-Response Relationship, Drug; Ly

1976